124 related articles for article (PubMed ID: 7181497)
1. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Ho JL; Klempner MS
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.
Tuazon CU; Lin MY; Sheagren JN
Antimicrob Agents Chemother; 1978 May; 13(5):759-61. PubMed ID: 666300
[TBL] [Abstract][Full Text] [Related]
4. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
Brandt CM; Rouse MS; Tallan BM; Wilson WR; Steckelberg JM
Antimicrob Agents Chemother; 1994 Sep; 38(9):2191-3. PubMed ID: 7811044
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
Maduri Traczewski M; Goldmann DA; Murphy P
Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
Johnston BL; Kwok RY; Mulligan ME
Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
[TBL] [Abstract][Full Text] [Related]
7. Interaction between vancomycin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Guerriero JC
Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276
[TBL] [Abstract][Full Text] [Related]
8. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
[TBL] [Abstract][Full Text] [Related]
9. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
Van der Auwera P; Klastersky J
Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.
Watanakunakorn C; Glotzbecker C
Antimicrob Agents Chemother; 1977 Sep; 12(3):346-8. PubMed ID: 907328
[TBL] [Abstract][Full Text] [Related]
11. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Sande MA; Courtney KB
J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
[TBL] [Abstract][Full Text] [Related]
12. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
Hackbarth CJ; Chambers HF; Sande MA
Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
[TBL] [Abstract][Full Text] [Related]
14. Nafcillin and oxacillin: comparative antistaphylococcal activity in mice.
Yurchenco JA; Hopper MW; Vince TD; Warren GH
J Antibiot (Tokyo); 1976 Apr; 29(4):460-5. PubMed ID: 931814
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
Egert J; Carrizosa J; Kaye D; Kobasa WD
J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
[TBL] [Abstract][Full Text] [Related]
16. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
17. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N
Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814
[TBL] [Abstract][Full Text] [Related]
18. Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
Ruane PJ; Morgan MA; Citron DM; Mulligan ME
J Clin Microbiol; 1986 Sep; 24(3):490-2. PubMed ID: 3489732
[TBL] [Abstract][Full Text] [Related]
19. In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.
Lalouckova K; Skrivanova E; Rondevaldova J; Frankova A; Soukup J; Kokoska L
Sci Rep; 2021 Jan; 11(1):177. PubMed ID: 33420288
[TBL] [Abstract][Full Text] [Related]
20. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
